TAMs preferentially secrete TGF-β to stimulate CSC-like properties by inducing EMT, while TAM-derived IL-6 induces CD44+ HCC stem cell expansion by activating STAT3, thus promoting tumor development through CSC growth. Here, TGFB1 is linked to hepatocellular carcinoma.